Related Experiment Video
Updated: Jun 14, 2025
12:34
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
Published on: January 12, 2024
774
Agrimonia coreana Extract Exerts Its Therapeutic Effect through CRAC Channel Inhibition for Atopic Dermatitis
Jintae Kim1, Ji Min Lee1,2, Su Jin Park1,2
1Channelopathy Research Center (CRC), Dongguk University College of Medicine, 32 Dongguk-ro, Ilsan Dong-gu, Goyang 10326, Gyeonggi-do, Republic of Korea.
International Journal of Molecular Sciences
|August 29, 2024
Summary
Agrimonia coreana extract (ACext) offers a novel approach to treating atopic dermatitis (AD). This natural extract effectively reduces inflammation and improves skin barrier function in AD models, presenting a promising alternative to traditional therapies.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Atopic dermatitis (AD) is a prevalent inflammatory skin disease characterized by itching and a compromised skin barrier.
- Current treatments like topical corticosteroids have side effects, necessitating safer therapeutic options.
- The immune response in AD involves T lymphocytes and environmental factors, exacerbating epidermal dysfunction.
Purpose of the Study:
- To investigate the therapeutic potential of *Agrimonia coreana* extract (ACext) for atopic dermatitis symptoms.
- To elucidate the mechanism of action of ACext in modulating immune responses related to AD.
- To evaluate the efficacy of ACext in an established mouse model of atopic dermatitis.
Main Methods:
- Assessed the inhibitory effects of ACext on CRAC (Calcium Release-Activated Calcium) channels and intracellular calcium signaling.
- Measured IL-2 levels and T cell proliferation following ACext treatment.
- Utilized a mouse model of AD to evaluate ACext's impact on clinical symptoms, skin histology, and barrier function.
Main Results:
- ACext demonstrated significant inhibition of CRAC channel activity, reducing Orai1/CRAC currents and intracellular calcium influx.
- ACext treatment led to decreased IL-2 production and suppressed T cell proliferation.
- In vivo studies showed that ACext markedly improved AD symptoms, enhanced histological parameters, and restored skin barrier integrity in mice.
Conclusions:
- ACext effectively inhibits key signaling pathways involved in AD pathogenesis, including CRAC channel activity and T cell responses.
- ACext demonstrates significant therapeutic benefits in a preclinical model of atopic dermatitis.
- Agrimonia coreana extract represents a promising natural compound for the development of novel, safer treatments for atopic dermatitis.
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:21G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
251
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228